Association between breastfeeding and osteoporotic hip fracture in women: a dose-response meta-analysis

Haixiang Xiao1, Quan Zhou2, Gouqi Niu3

  • 1Department of Orthopedics, Jingjiang People's Hospital, Jingjiang, 214500, China.

Insights

Breastfeeding reduces the risk of osteoporotic hip fractures in women. Longer breastfeeding duration, up to 25 months, shows a greater decrease in fracture incidence, highlighting its bone health benefits.

Area of Science:

  • Osteoporosis Research
  • Maternal and Child Health
  • Geriatric Medicine

Background:

  • Breastfeeding is crucial for infant development, supplying approximately 300 mg of calcium daily.
  • Women can experience 5-10% bone loss during breastfeeding, increasing osteoporosis risk.
  • Osteoporotic hip fractures represent a significant health concern, particularly in older adults.

Purpose of the Study:

  • To investigate the association between breastfeeding and the incidence of osteoporotic hip fractures in women.
  • To analyze the dose-response relationship between breastfeeding duration and hip fracture risk.

Main Methods:

  • A meta-analysis was conducted using studies from PubMed and Embase up to May 2019.
  • Study quality was assessed using the Methodological Index for Non-Randomized Studies (MINORS).
  • A dose-response meta-analysis employed the generalized least squares for trend estimation method.

Main Results:

  • Seven moderate to high-quality studies involving 103,898 subjects were included.
  • Breastfeeding was associated with a reduced incidence of osteoporotic hip fractures (RR = 0.64).
  • A dose-response relationship was observed: longer breastfeeding duration correlated with lower fracture risk, with significant effects up to 24 months.

Conclusions:

  • Extended breastfeeding duration is linked to a decreased incidence of osteoporotic hip fractures.
  • The protective effect of breastfeeding on hip fracture risk was significant for durations up to 25 months.
  • No significant association was found for breastfeeding durations exceeding 25 months.
Abstract

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.1K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
4.8K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
4.6K